Insider buying on Oct 7, 2026
Insiders at 10 companies reported 105 open-market buys of their own stock on Oct 7, 2026. Plan trades are left out.
Newest first
WhoTradeCompanyValueTradedThe stock’s closing price from the first session on or after the trade day to the latest close, with the S&P 500 over the same days. A fact about the stock, not a result anyone earned.
AJB Investment Fund IIMajor shareholderBought
Jewett Cameron TradingJCTC$41.0114 shares at $2.93Oct 525d agoStock since trade−5.0%Oct 5, 2026 close $2.97 → Oct 29, 2026 close $2.82. S&P 500 −0.3% over the same days.
Ivan BrockmanDirectorBoughtRaised their holding by 400%
Vera BradleyVRA$50.2K10,000 shares at $5.02Oct 624d agoStock since trade+30.7%Oct 6, 2026 close $5.08 → Oct 29, 2026 close $6.64. S&P 500 −0.9% over the same days.
Robert TaglichMajor shareholderBoughtRaised their holding by 0.9%
IntellineticsINLX$20K4,000 shares at $5.00Oct 624d agoStock since trade−14.2%Oct 6, 2026 close $4.85 → Oct 29, 2026 close $4.16. S&P 500 −0.9% over the same days.
Paul P. RusnakMajor shareholderBought
Sonic AutomotiveSAH$67K1,119 shares at $59.90Oct 624d agoStock since trade+4.3%Oct 6, 2026 close $61.00 → Oct 29, 2026 close $63.61. S&P 500 −0.9% over the same days.
Saba Capital ManagementMajor shareholderBoughtRaised their holding by 0.1%
Gabelli Healthcare & WellnessRx TrustGRX$16.6K1,775 shares at $9.38Oct 525d agoStock since trade+7.9%Oct 5, 2026 close $9.39 → Oct 29, 2026 close $10.13. S&P 500 −0.3% over the same days.
Saba Capital ManagementMajor shareholderBoughtRaised their holding by 0.7%
New Germany FundGF$264.3K25,144 shares at $10.51Oct 525d agoStock since trade−1.8%Oct 5, 2026 close $10.49 → Oct 29, 2026 close $10.30. S&P 500 −0.3% over the same days.
Saba Capital ManagementMajor shareholderBoughtRaised their holding by 1.1%
Mexico FundMXF$520.3K25,900 shares at $20.09Oct 525d agoStock since trade+0.5%Oct 5, 2026 close $20.05 → Oct 29, 2026 close $20.14. S&P 500 −0.3% over the same days.
David R. EpsteinDirectorBoughtRaised their holding by 100%
AgomAb TherapeuticsAGMB$43.5K5,000 shares at $8.70Oct 624d agoStock since trade−10.1%Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days.
David R. EpsteinDirectorBoughtNew holdingAgomAb TherapeuticsAGMB$42.9K5,000 shares at $8.57Oct 525d agoStock since trade−8.5%Oct 5, 2026 close $8.69 → Oct 29, 2026 close $7.95. S&P 500 −0.3% over the same days.
Pierre Thadee Victor KemulaChief Financial OfficerBoughtRaised their holding by 25%AgomAb TherapeuticsAGMB$17.1K2,000 shares at $8.54Oct 624d agoStock since trade−10.1%Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days.